NCT02320643

A Pilot Study to Investigate the Efficacy of Partially Absorbable Mesh in Patients With Pelvic Organ Prolapsed

A Prospective Pilot Study to Investigate the Efficacy of Partially Absorbable Mesh(Seratom PA®) in Patients With Pelvic Organ Prolapsed

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 50 (actual)
• Sponsor: Samyang Biopharmaceuticals Corporation · Industry
• Sex: Female
• Age: 41 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate the efficacy, recurrence, postoperative complications of partially absorbable mesh(Seratom®PA) in patients with pelvic organ prolapse.

Detailed description

Patients with pelvic organ prolapse are administrated partially absorbable mesh(Seratom®PA). It is performed pelvic organ prolapse quantification(POP-Q) examination, quality of life(QOL) questionnaire complications at postop 2week, 12week, 24week.

Conditions

• Pelvic Organ Prolapse

Interventions

Type	Name	Description
DEVICE	Seratom® PA mesh	Partially absorbable mesh

Timeline

• Start date: 2014-12-01
• Primary completion: 2016-11-01
• Completion: 2017-04-01
• First posted: 2014-12-19
• Last updated: 2017-05-01

Locations

1 site across 1 country: South Korea